Emerging urinary markers of renal injury in obstructive nephropathy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lucarelli, Giuseppe ^a   Mancini, Vito ^a   Galleggiante, Vanessa ^a   Rutigliano, Monica ^a   Vavallo, Antonio ^a   Battaglia, Michele ^a   Ditonno, Pasquale ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; KIDNEY INJURY MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

APOPTOSIS; ATROPHY; CELL INFILTRATION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HUMAN; INFLAMMATORY CELL; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; META ANALYSIS (TOPIC); OBSTRUCTIVE NEPHROPATHY; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; URINARY EXCRETION; URINARY TRACT OBSTRUCTION; ACUTE KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; KIDNEY TUBULE; PATHOLOGY; URETER OBSTRUCTION; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; EPIDERMAL GROWTH FACTOR; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; URETERAL OBSTRUCTION;

EID: 84904700034     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/303298     Document Type: Review

References (62)

1. Chevalier R. L., Thornhill B. A., Forbes M. S., Kiley S. C., Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatric Nephrology 2010 25 4 687 697 10.1007/s00467-009-1316-5 2-s2.0-77951253854
2. Quinlan M. R., Docherty N. G., Watson R. W. G., Fitzpatrick J. M., Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction. The American Journal of Physiology-Renal Physiology 2008 295 1 F1 F11 10.1152/ajprenal.00576.2007 2-s2.0-49949084432
3. Matthews B. D., Overby D. R., Mannix R., Ingber D. E., Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. Journal of Cell Science 2006 119 3 508 518 10.1242/jcs.02760 2-s2.0-33644967727
4. Goel M., Sinkins W. G., Zuo C. D., Estacion M., Schilling W. P., Identification and localization of TRPC channels in the rat kidney. American Journal of Physiology-Renal Physiology 2006 290 5 F1241 F1252 10.1152/ajprenal.00376.2005 2-s2.0-33646585142 (Pubitemid 43724925)
5. Rohatgi R., Flores D., Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Current Opinion in Nephrology and Hypertension 2010 19 1 65 71 10.1097/MNH.0b013e32833327f3 2-s2.0-73849089954
6. Mezzano S. A., Ruiz-Ortega M., Egido J., Angiotensin II and renal fibrosis. Hypertension 2001 38 3, part 2 635 638 10.1161/hy09t1.094234 2-s2.0-0035462888
7. Rüster C., Wolf G., Renin-angiotensin-aldosterone system and progression of renal disease. Journal of the American Society of Nephrology 2006 17 11 2985 2991 10.1681/ASN.2006040356 (Pubitemid 44707758)
8. Morrissey J. J., Ishidoya S., McCracken R., Klahr S., Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. Journal of the American Society of Nephrology 1996 7 10 2202 2212 2-s2.0-0030404820 (Pubitemid 27468250)
9. Felsen D., Schulsinger D., Gross S. S., Kim F. Y., Marion D., Vaughan E. D. Jr., Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide. Journal of Urology 2003 169 1 373 376 10.1016/S0022-5347(05)64130-4 2-s2.0-0037212691 (Pubitemid 35461649)
10. Felsen D., Dardashti K., Ostad M., Lemer M. L., Gross S. S., Chen J., Vaughan E. D. Jr., Poppas D. P., Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction. Journal of Urology 2003 169 4 1569 1572 10.1097/01.ju.0000054885.51858.99 2-s2.0-0037377174 (Pubitemid 36323846)
11. Brasier A. R., Li J., Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996 27 3, part 2 465 475 10.1161/01.HYP.27.3. 465 2-s2.0-0029979243 (Pubitemid 26086217)
12. Li J., Brasier A. R., Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (nuclear factor- B p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Molecular Endocrinology 1996 10 3 252 264 10.1210/me.10.3.252 2-s2.0-0029930466 (Pubitemid 26082697)
13. Zhang G., Oldroyd S. D., Huang L. H., Yang B., Li Y., Ye R., El Nahas A. M., Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Experimental Nephrology 2001 9 2 71 80 10.1159/000052597 2-s2.0-0035164489 (Pubitemid 32041484)
14. Docherty N. G., O'Sullivan O. E., Healy D. A., Fitzpatrick J. M., Watson R. W. G., Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. The American Journal of Physiology-Renal Physiology 2006 290 1 F4 F13 10.1152/ajprenal.00045.2005 2-s2.0-33644789780
15. Liu Y., New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology 2010 21 2 212 222 10.1681/ASN.2008121226 2-s2.0-77949351029
16. Grandaliano G., Gesualdo L., Bartoli F., Ranieri E., Monno R., Leggio A., Paradies G., Caldarulo E., Infante B., Schena F. P., MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney International 2000 58 1 182 192 10.1046/j.1523-1755.2000.00153.x 2-s2.0-0033921151 (Pubitemid 30429863)
17. Bartoli F., Penza R., Aceto G., Niglio F., D'Addato O., Pastore V., Campanella V., Magaldi S., Lasalandra C., Di Bitonto G., Gesualdo L., Urinary epidermal growth factor, monocyte chemotactic protein-1, and β 2-microglobulin in children with ureteropelvic junction obstruction. Journal of Pediatric Surgery 2011 46 3 530 536 10.1016/j.jpedsurg.2010.07.057 2-s2.0-79952274744
18. Segerer S., Nelson P. J., Schlöndorff D., Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. Journal of the American Society of Nephrology 2000 11 1 152 176 2-s2.0-0033971775 (Pubitemid 30020438)
19. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Montinaro V., Marra F., Schena F. P., Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. Journal of the American Society of Nephrology 1996 7 6 906 913 2-s2.0-0030377417 (Pubitemid 27465985)
20. Diamond J. R., Kees-Folts D., Frye J. E., Restrepo N. C., Macrophages, monocyte chemoattractant peptide-1, and TGF-beta1 in experimental hydronephrosis. American Journal of Physiology 1994 266 6 F926 F933 2-s2.0-0027962871
21. Eardley K. S., Zehnder D., Quinkler M., Lepenies J., Bates R. L., Savage C. O., Howie A. J., Adu D., Cockwell P., The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney International 2006 69 7 1189 1197 10.1038/sj.ki.5000212 2-s2.0-33645525811
22. Ma L., Yang H., Gaspert A., Carlesso G., Barty M. M., Davidson J. M., Sheppard D., Fogo A. B., Transforming growth factor- β -dependent and -independent pathways of induction of tubulointerstitial fibrosis in β 6(-/-) mice. The American Journal of Pathology 2003 163 4 1261 1273 10.1016/S0002-9440(10)63486-4 2-s2.0-0141537244 (Pubitemid 37175076)
23. Sato M., Muragaki Y., Saika S., Roberts A. B., Ooshima A., Targeted disruption of TGF- β 1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Journal of Clinical Investigation 2003 112 10 1486 1494 10.1172/JCI200319270 2-s2.0-0346727324 (Pubitemid 38056275)
24. Misseri R., Meldrum D. R., Dinarello C. A., Dagher P., Hile K. L., Rink R. C., Meldrum K. K., TNF- α mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. The American Journal of Physiology: Renal Physiology 2005 288 2 F406 F411 10.1152/ajprenal.00099.2004 2-s2.0-12144277463 (Pubitemid 40105400)
25. Gesualdo L., Di Paolo S., Calabró A., Milani S., Maiorano E., Ranieri E., Pannarale G., Schena F. P., Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney International 1996 49 3 656 665 10.1038/ki.1996.94 2-s2.0-0029968917 (Pubitemid 26093074)
26. Storch S., Saggi S., Megyesi J., Price P. M., Safirstein R., Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney International 1992 42 1 89 94 10.1038/ki.1992.265 2-s2.0-0026633139
27. Humes H. D., Cieslinski D. A., Coimbra T. M., Messana J. M., Galvao C., Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. Journal of Clinical Investigation 1989 84 6 1757 1761 10.1172/JCI114359 2-s2.0-0024814755 (Pubitemid 20016178)
28. Kennedy W. A. II, Buttyan R., Garcia-Montes E., Olsson C. A., Sawczuk I. S., Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction. Urology 1997 49 6 973 980 10.1016/S0090-4295(97)00101-5 2-s2.0-0030925355 (Pubitemid 27246977)
29. Torres D. D., Rossini M., Manno C., Mattace-Raso F., D'Altri C., Ranieri E., Pontrelli P., Grandaliano G., Gesualdo L., Schena F. P., The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney International 2008 73 3 327 333 10.1038/sj.ki.5002621 2-s2.0-38149128235
30. Chevalier R. L., Kim A., Thornhill B. A., Wolstenholme J. T., Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney International 1999 55 3 793 807 10.1046/j.1523-1755.1999.055003793.x 2-s2.0-0033029428 (Pubitemid 29100692)
31. Chevalier R. L., Thornhill B. A., Chang A. Y., Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney International 2000 58 5 1987 1995 10.1046/j.1523-1755.2000.00371.x 2-s2.0-0033736229
32. Ito K., Chen J., El Chaar M., Stern J. M., Seshan S. V., Khodadadian J. J., Richardson I., Hyman M. J., Vaughan E. D. Jr., Poppas D. P., Felsen D., Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. The American Journal of Physiology-Renal Physiology 2004 287 6 F1283 F1293 10.1152/ajprenal.00441.2003 2-s2.0-8644276387 (Pubitemid 39507237)
33. Lucarelli G., Ditonno P., Bettocchi C., Grandaliano G., Gesualdo L., Selvaggi F. P., Battaglia M., Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury. Journal of Urology 2013 189 3 960 965 10.1016/j.juro.2012.08.242 2-s2.0-84873731045
34. Bartoli F., Gesualdo L., Paradies G., Caldarulo E., Infante B., Grandaliano G., Monno R., Leggio S., Salzillo F., Schena F. P., Leggio A., Renal expression of monocyte chemotactic protein-1 and epidermal growth factor in children with obstructive hydronephrosis. Journal of Pediatric Surgery 2000 35 4 569 572 10.1053/jpsu.2000.0350569 2-s2.0-12944281825 (Pubitemid 30181029)
35. Chertin B., Farkas A., Puri P., Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy. European Urology 2003 44 1 144 149 10.1016/S0302-2838(03)00190-8 2-s2.0-0038311849 (Pubitemid 36741390)
36. Munshi R., Johnson A., Siew E. D., Ikizler T. A., Ware L. B., Wurfel M. M., Himmelfarb J., Zager R. A., MCP-1 gene activation marks acute kidney injury. Journal of the American Society of Nephrology 2011 22 1 165 175 10.1681/ASN.2010060641 2-s2.0-78651382290
37. Flower D. R., The lipocalin protein family: structure and function. Biochemical Journal 1996 318, part 1 1 14 2-s2.0-0029790266 (Pubitemid 26283618)
38. Mishra J., Qing M. A., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 2003 14 10 2534 2543 10.1097/01.ASN. 0000088027.54400.C6 2-s2.0-0141678253 (Pubitemid 37169339)
39. Schmidt-Ott K. M., Mori K., Jau Y. L., Kalandadze A., Cohen D. J., Devarajan P., Barasch J., Dual action of neutrophil gelatinase-associated lipocalin. Journal of the American Society of Nephrology 2007 18 2 407 413 10.1681/ASN.2006080882 2-s2.0-33846682720 (Pubitemid 46193306)
40. Nickolas T. L., O'Rourke M. J., Yang J., Sise M. E., Canetta P. A., Barasch N., Buchen C., Khan F., Mori K., Giglio J., Devarajan P., Barasch J., Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Annals of Internal Medicine 2008 148 11 810 819 10.7326/0003-4819-148- 11-200806030-00003 2-s2.0-44649166336 (Pubitemid 351786928)
41. Kuwabara T., Mori K., Mukoyama M., Kasahara M., Yokoi H., Saito Y., Yoshioka T., Ogawa Y., Imamaki H., Kusakabe T., Ebihara K., Omata M., Satoh N., Sugawara A., Barasch J., Nakao K., Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney International 2009 75 3 285 294 10.1038/ki.2008.499 2-s2.0-58349107121
42. Ding H., He Y., Li K., Yang J., Li X., Lu R., Gao W., Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clinical Immunology 2007 123 2 227 234 10.1016/j.clim.2007.01.010 2-s2.0-34247223097 (Pubitemid 46613869)
43. Noto A., Cibecchini F., Fanos V., Mussap M., NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. BioMed Research International 2013 2013 6 612032 10.1155/2013/612032 2-s2.0-84876576539
44. Haase-Fielitz A., Haase M., Devarajan P., Neutrophil gelatinase- associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Annals of Clinical Biochemistry 2014 51, part 3 335 351
45. Wasilewska A., Taranta-Janusz K., Dbek W., Zoch-Zwierz W., Kuroczycka-Saniutycz E., KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatric Nephrology 2011 26 4 579 586 10.1007/s00467-011-1773-5 2-s2.0-79954443701
46. Cost N. G., Noh P. H., Devarajan P., Ivancic V., Reddy P. P., Minevich E., Bennett M., Haffner C., Schulte M., DeFoor W. R. Jr., Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. Journal of Urology 2013 190 4, supplement 1462 1467 10.1016/j.juro.2013.05.003 2-s2.0-84881649108
47. Lim A. I., Tang S. C. W., Lai K. N., Leung J. C. K., Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? Journal of Cellular Physiology 2013 228 5 917 924 10.1002/jcp.24267 2-s2.0-84873849583
48. Han W. K., Bailly V., Abichandani R., Thadhani R., Bonventre J. V., Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney International 2002 62 1 237 244 10.1046/j.1523-1755.2002. 00433.x 2-s2.0-0036314217 (Pubitemid 34754067)
49. Han W. K., Wagener G., Zhu Y., Wang S., Lee H. T., Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clinical Journal of the American Society of Nephrology 2009 4 5 873 882 10.2215/CJN.04810908 2-s2.0-68049144273
50. Liangos O., Perianayagam M. C., Vaidya V. S., Han W. K., Wald R., Tighiouart H., MacKinnon R. W., Li L., Balakrishnan V. S., Pereira B. J. G., Bonventre J. V., Jaber B. L., Urinary N-acetyl- β -(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology 2007 18 3 904 912 10.1681/ASN.2006030221 2-s2.0-33947262956 (Pubitemid 46434507)
51. van Timmeren M. M., van den Heuvel M. C., Bailly V., Bakker S. J. L., van Goor H., Stegeman C. A., Tubular kidney injury molecule-1 (KIM-1) in human renal disease. Journal of Pathology 2007 212 2 209 217 10.1002/path.2175 2-s2.0-34249814303 (Pubitemid 46852099)
52. Van Timmeren M. M., Vaidya V. S., Van Ree R. M., Oterdoom L. H., De Vries A. P. J., Gans R. O. B., Van Goor H., Stegeman C. A., Bonventre J. V., Bakker S. J. L., High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007 84 12 1625 1630 10.1097/01.tp.0000295982.78039.ef 2-s2.0-37549009988
53. Zhang P. L., Rothblum L. I., Han W. K., Blasick T. M., Potdar S., Bonventre J. V., Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney International 2008 73 5 608 614 10.1038/sj.ki.5002697 2-s2.0-39349098768 (Pubitemid 351264105)
54. Szeto C., Kwan B. C., Lai K., Lai F. M., Chow K., Wang G., Luk C. C., Li P. K., Urinary expression of kidney injury markers in renal transplant recipients. Clinical Journal of the American Society of Nephrology 2010 5 12 2329 2337 10.2215/CJN.01910310 2-s2.0-78650381320
55. Lucarelli G., Bettocchi C., Battaglia M., Impedovo S. V., Vavallo A., Grandaliano G., Castellano G., Schena F. P., Selvaggi F. P., Ditonno P., Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years. Transplantation Proceedings 2010 42 4 1104 1107 10.1016/j.transproceed.2010.03.059 2-s2.0-77952580408
56. Impedovo S. V., De Lorenzis E., Volpe A., Gesualdo L., Grandaliano G., Palazzo S., Lucarelli G., Bettocchi C., Terrone C., Stratta P., Quaglia M., Battaglia M., Ditonno P., Middle and long-term outcomes of dual kidney transplant: a multicenter experience. Transplantation Proceedings 2013 45 3 1237 1241 10.1016/j.transproceed.2013.02.031 2-s2.0-84876832243
57. Lucarelli G., Fanelli M., Larocca A. M. V., Germinario C. A., Rutigliano M., Vavallo A., Selvaggi F. P., Bettocchi C., Battaglia M., Ditonno P., Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/mL. Prostate 2012 72 15 1611 1621 10.1002/pros.22514 2-s2.0-84867069711
58. Lucarelli G., Ditonno P., Bettocchi C., Spilotros M., Rutigliano M., Vavallo A., Galleggiante V., Fanelli M., Larocca A. M. V., Germinario C. A., Maiorano E., Selvaggi F. P., Battaglia M., Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. Future Oncology 2013 9 6 899 907 10.2217/fon.13.50 2-s2.0-84878513309
59. Lucarelli G., Rutigliano M., Bettocchi C., Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer. Journal of Urology 2013 190 6 2271 2277 10.1016/j.juro.2013.05.004
60. Lucarelli G., Ditonno P., Bettocchi C., Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. Disease Markers 2014 2014 9 689795 10.1155/2014/689795
61. Han W. K., Alinani A., Wu C. L., Michaelson D., Loda M., McGovern F. J., Thadhani R., Bonventre J. V., Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. Journal of the American Society of Nephrology 2005 16 4 1126 1134 10.1681/ASN.2004070530 2-s2.0-24344507726 (Pubitemid 41710324)
62. Xue W., Xie Y., Wang Q., Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase -associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Nephrology 2014 19 4 186 194 10.1111/nep.12173